Detalles de la búsqueda
1.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 69(6): 2165-2174, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594435
2.
Dutch normative data of the sexual distress scale and the body image scale.
Qual Life Res
; 32(10): 2829-2837, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37193810
3.
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study.
Inflamm Bowel Dis
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38666643
4.
Handling missing values in the analysis of between-hospital differences in ordinal and dichotomous outcomes: a simulation study.
BMJ Qual Saf
; 32(12): 742-749, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734955
5.
Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry.
JMIR Res Protoc
; 12: e43230, 2023 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36995758
6.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736339
7.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310877
8.
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
Therap Adv Gastroenterol
; 14: 17562848211012595, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33995584
Resultados
1 -
8
de 8
1
Próxima >
>>